Brian Doyle, MD
Article
Longer-term Outcomes in Critically Ill Patients with COVID-19 in the REMAP-CAP Trial
March 1, 2024
Clinical question: What is the longer-term (180-day) mortality effect of common therapies on critically ill patients with COVID-19? Background: Most randomized clinical trials for patients with...